CARLSMED, INC. (CARL) Guidance & Earnings Results
On 2026-08-05 CARLSMED, INC. raised guidance: "Raised to $74-78M from…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CARLCARLSMED, INC.Follow CARL — free
—
Price chart with a free account
- Market cap
- 396.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Raised | Raised to $74-78M from $72-77M · full year |
| 5 May 26 | Raised | FY26 revenue raised to $72-77M from $70-75M; midpoint $74.5M representing 48% growth over 2025 · full year |
| 25 Feb 26 | Raised | FY2026 revenue $70-75M, representing 44% growth at midpoint over FY2025 revenue of $50.5M · full year |
| 6 Nov 25 | Raised | FY25 revenue raised to $49.0-50.0M from $45.5-47.5M · full year |
| 28 Aug 25 | Raised | FY2025 revenue $45.5-47.5M, representing 67-75% growth over FY2024 · full year |
CARLSMED, INC. — questions
- What guidance did CARLSMED, INC. give?
- On 2026-08-05: "Raised to $74-78M from $72-77M"
- When does CARLSMED, INC. report earnings?
- CARLSMED, INC.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from CARLSMED, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.